Editor-in-Chief: Michael F. Drummond, MCom, DPhil

(May 2018 – June 2020)
University of York
York, England, UK
Contact Editors

drummond_mikeMichael F. Drummond is Professor of Health Economics and former Director of the Centre for Health Economics at the University of York. His particular field of interest is in the economic evaluation of healthcare treatments and programs. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programs, services for people with AIDS, eye healthcare and pharmaceuticals. He is the author of two major textbooks and more than 550 scientific papers, has acted as a consultant to the World Health Organization and was Project Leader for the European Union Project on the Methodology of Economic Appraisal of Health Technology. He has been President of the International Society of Technology Assessment in Health Care, and of ISPOR. He is currently a member of the Guidelines Review Panels of the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom, and is a Principal Consultant for i3Innovus. In 2008, he received an Honorary Doctor of Science from City University, London.

Value in Health Vision Statement

Value in Health should duplicate ISPOR’s objectives to have the journal reflect the highest scientific quality as possible in the areas of methodological research and healthcare sciences, services, and policy, whilst maintaining the already broad appeal to the journal it has already attained, and continuing contributions from many world leaders associated with NICE, Centers for Medicare and Medicaid Services, and major private health insurers around the globe.

Editor-in-Chief: C. Daniel Mullins, PhD

(May 2018 – June 2022)
University of Maryland
Baltimore, MD, USA
Contact Editors

mullins_daniel-photoC. Daniel Mullins is a Professor and Chair of the Pharmaceutical Health Services Research Department at the University of Maryland School of Pharmacy. He is Founder and Executive Director of the University of Maryland PATient-centered Involvement in Evaluating effectiveNess of TreatmentS (PATIENTS) Program, an infrastructure to support patient-centered outcomes research and related training activities. He also serves as Director of the Community and Collaboration Core within the university’s Institute for Clinical and Translational Research. Dr Mullins has received funding as a Principal Investigator from the NIH/NIA, NIH/NHLBI, AHRQ, the Patient-Centered Outcomes Research Institute (PCORI) and various patient advocacy and industry organizations. He has served as a Regular Member of AHRQ and NCI Study Sections and has chaired PCORI Study Sections. Dr Mullins is author/co-author of more than 250 peer-reviewed articles. He has received an Outstanding Service Award from the Drug Information Association and two Service Awards from ISPOR. In 2007, he received the Dr Patricia Sokolove Outstanding Mentor Award from the University of Maryland Baltimore campus-wide Graduate Student Association. In 2013, he was the recipient of the Dr Daniel D. Savage Memorial Science Award, the Association of Black Cardiologists’ most prestigious annual award. Also in 2013, he was awarded a University System of Maryland Wilson H. Elkins Professorship. He was named Researcher of the Year in 2014 and received the Martin Luther King Faculty Diversity Award in 2017 for the University of Maryland Baltimore campus and the ISPOR Marilyn Dix Smith Leadership Award.

Value in Health Vision Statement

As the journal of ISPOR, Value in Health should be viewed as interdependent of the Society and mirror its aim to enhance the methods and applications within the fields of health economics and outcomes research, with its content reflecting research that is read and used for medical decision making and reflect empirical applications of readable, reliable, and advanced methodologies with actionable results and conclusions.

Associate Editors

Contact Editors

Sarah Acaster, PSc, MSc

(August 2018 – November 2022)
Acaster Lloyd Consulting Ltd
London, England, UK

Kalipso Chalkidou, MD, PhD

(August 2018 – August 2022)
Imperial College of London
London, England, UK

Joshua P. Cohen, PhD

(June 2017 – June 2021)
Independent Healthcare Analyst
Boston, MA, USA

David M. Epstein, MSc, PhD

(November 2015 – November 2019)
University of Granada
Granada, Spain

Manuel A. Espinoza, PhD, MD, MSc

(February 2018 – February 2022)
Pontificia Universidad Católica de Chile
Santiago, Chile

Alex Z. Fu, PhD

(April 2016 – April 2020)
Georgetown University
Washington, DC, USA

Ron Goeree, MA

(April 2016 – April 2020)
McMaster University
Hamilton, ON, Canada

Fei-Yuan Sharon Hsiao, PhD

(September 2018 – September 2022)
National Taiwan University
Taipei, Taiwan

Stacie Hudgens, MA

(July 2016 – July 2020)
Clinical Outcomes Solutions, LLC
Tucson, AZ, USA

Lori McLeod, PhD

(January 2017 – January 2021)
RTI Health Solutions
Research Triangle Park, NC, USA

Claire Rothery McKenna, PhD

(November 2015 – November 2019)
University of York
York, England, UK

Axel Mühlbacher, PhD

(September 2018 – September 2022)
Neubrandenburg University
Neubrandenburg, Germany

Richard Norman, PhD, MSc

(March 2016 – March 2020)
Curtin University
Perth, Australia

Maarten J. Postma, PhD

(June 2017 – June 2021)
University of Groningen
Groningen, The Netherlands

Thomas Rapp, PhD

(July 2016 – July 2020)
Harvard University
Boston, MA, USA

Lizheng Shi, PhD, MsPharm, MA

(July 2018 – July 2022)
Tulane University
New Orleans, LA, USA

Elly Stolk, PhD

(September 2018 – September 2022)
Erasmus University Rotterdam
Rotterdam, The Netherlands

Aleksandra Torbica, PhD

(November 2015 – November 2019)
Universita Bocconi
Milan, Italy

David J. Vanness, PhD

(September 2018 – September 2022)
Pennsylvania State University
University Park, PA, USA

David Veenstra, PhD, PharmD

(June 2017 – June 2021)
University of Washington
Seattle, WA, USA

Allan J. Wailoo, PhD, BSc, MA

(April 2017 – April 2021)
University of Sheffield
Sheffield, England, UK

Danielle M. Whicher, PhD, MHS

(August 2018 – August 2022)
Washington, DC, USA

Editorial Advisory Board

Alan Brennan, PhD
(March 2017 – March 2021)
University of Sheffield
Sheffield, England, UK

Kati Copley-Merriman, MS, MBA
(November 2019 - November 2022)
RTI Health Solutions
Ann Arbor, MI, USA

John C. Hornberger, MD, MS
(March 2017 – March 2021)
Genomic Health, Inc
Redwood City, CA, USA

John Hsu, PhD
(February 2019 - February 2023)
Harvard University
Cambridge, MA, USA

Andrea Manca, PhD, MSc
(March 2016 – March 2020)
University of York
York, England, UK

Robert L. Ohsfeldt, PhD
(November 2017 – November 2021)
Texas A&M University
College Station, TX, USA

Kathryn A. Phillips, PhD
(March 2017 – March 2021)
University of California San Francisco
San Francisco, CA, USA

Shelby D. Reed, PhD, RPh
(February 2017 – January 2021)
Duke Clinical Research Institute
Durham, NC, USA

Brian Rittenhouse, PhD
(March 2016 – March 2020)
Massachusetts College of Pharmacy and Health Services
Boston, MA, USA

Paul A. Scuffham, PhD, BA
(March 2016 – March 2020)
Griffith University
Queensland, Australia

Johan L. Severens, PhD
(April 2016 – April 2020)
Erasmus School of Health Policy & Management
Rotterdam, The Netherlands

Ya-Chen (Tina) Shih, PhD
(February 2019 – February 2023)
University of Texas MD Anderson Cancer Center
Houston, TX, USA

Management Advisory Board

Jalpa A. Doshi, PhD (chair)
University of Pennsylvania
Philadelphia, PA, USA

Rok Hren, PhD, MSc
Siemens Healthineers
Ljubljana, Slovenia

Rosanna Tarricone, PhD, MSc
Bocconi University
Milan, Italy

Editorial Office

505 Lawrence Square Blvd South
Lawrenceville, NJ, USA 08648
Contact Editors

Stephen L. Priori
Director, Publications

Lyn Beamesderfer
Associate Director, Publications & Communications

Jennifer A. Brandt
Editorial Assistant

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now